Contact Information
Company Information
Annual Revenue
27100000.0
Technologies
Outlook
ServiceNow
Zendesk
CloudFlare Hosting
Google Analytics
Google Tag Manager
Mobile Friendly
Remote
Keywords
aav
huntingtons disease
gene therapy
als
epilepsy
fabry disease
biotechnology: pharmaceutical preparations
health care
biotechnology research
huntington's disease
hemophilia b
gene silencing
clinical trials
patient advocacy
genomic medicine
innovative cures
clinical development
aav technology
biopharmaceutical
transformative therapies
unmet medical needs
investor relations
fda approvals
manufacturing facility
biotechnology
public offering
pipeline development
research programs
orphan diseases
life-changing therapies
patient community
expanding access
collaboration
biopharma innovation
genetic disorders
commercialization
adjunct therapies
clinical advancements
regulatory approval
patient-centric
social responsibility
quality manufacturing
leading science
customized treatments
gene delivery
preclinical candidates
biotech partnerships
patient resources
scientific publications
gene therapy leadership
advanced medical care
comprehensive healthcare
therapeutic innovation
healthcare transformation
severe genetic diseases
adeno-associated virus (aav)
amyotrophic lateral sclerosis (als)
temporal lobe epilepsy
alzheimer's disease
single-treatment cures
pharmaceutical
liver-directed therapies
central nervous system disorders
transformative treatments
patient outcomes
proprietary technology
partnerships
patient demographics
healthcare providers
research partners
competitive landscape
long-term treatment
quality & safety
chronic treatment alternatives
viral vector technology
patient impact
scientific excellence
health
wellness & fitness
hospital & health care
medical
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans